Educational only. Not medical advice. Invite-only research preview.No PHI. Do not share patient names or identifying information (HIPAA).
MytoIntelligence
All targets

Molecular target

ACE / RAAS Pathway

Angiotensin-Converting Enzyme is central to the renin–angiotensin–aldosterone system regulating blood pressure and vascular tone. Several plants (hibiscus, hawthorn, olive leaf) modulate components of this pathway.

10 drugs act here6 plants reach it via their compounds

Educational use only. This page summarizes published research and traditional-use records for educational purposes. It does not diagnose, treat, cure, or prevent any disease. Do not start, stop, or change medications based on this information. Discuss any decisions about therapies — pharmaceutical or botanical — with a qualified clinician who knows your medical history.

No PHI / HIPAA notice: Do not share Protected Health Information (PHI) of any patient on this site — including names, dates of birth, addresses, MRNs, or any identifying information. Use abstract case framing only. Sharing PHI with non-covered entities risks HIPAA violation regardless of platform capability.

Pharmaceutical agents

Drugs that act on ACE / RAAS Pathway

These medications have ACE / RAAS Pathway among their molecular targets. Sharing a target is a mechanistic relationship — it does not make any plant below an alternative to, or substitute for, these drugs.

Botanical connections

Plants whose compounds act on ACE / RAAS Pathway

Each plant below contains a named compound documented to act on ACE / RAAS Pathway. The compound and the reason for the connection are shown on every edge — a shared mechanism, not a therapeutic equivalence.

  • Anthocyanins (delphinidin, cyanidin glycosides)Anthocyanin

    Pigment compounds responsible for the deep red color; ACE inhibitory activity contributes to BP lowering.

  • Hibiscus acidOrganic acid

    Unique to hibiscus; competitive ACE inhibition demonstrated in vitro.

  • Buckwheat-derived ACE-inhibitory tripeptide (Gly-Pro-Pro)Bioactive peptide

    Ma et al. (2006) isolated and identified an ACE-inhibitory tripeptide (Gly-Pro-Pro) from buckwheat protein hydrolysates via consecutive chromatographic methods. Activity was demonstrated in vitro; in vivo and clinical data are not established in the available citations.

  • Amaranth protein hydrolysate peptidesBioactive peptides

    In vitro studies report that extruded amaranth pepsin/pancreatin hydrolysates may inhibit NF-κB signalling in LPS-stimulated macrophages and display ACE-inhibitory activity (Montoya-Rodríguez et al., 2014).

  • OleuropeinSecoiridoid

    Primary olive-leaf compound; ACE inhibition and antioxidant activity. Hydrolyzed in the gut to hydroxytyrosol.

  • Quercetinflavonoid

    Inhibits platelet aggregation via TXA2 pathway, mild ACE inhibition, and stabilizes mast cells (reducing histamine release).

  • Punicalagins (ellagitannins)Tannin

    Largest molecules in pomegranate juice; gut-microbiome-converted to urolithins which are the actually bioavailable downstream metabolites.

A shared molecular target shows how a botanical and a drug relate mechanistically. It is not evidence that one can replace the other. Educational summary only — discuss any medication decision with your clinician.